Recent content by CatFactorial

I don’t disagree, I just mean from the perspective of some addled policymaker, physicians are an easy if mistaken target

From the perspective of a policy maker aiming for affordable healthcare of reasonable quality, if IMGs can provide that for lower cost, I doubt US grads “deserve” anything? This is true, the lack of residency requirement opens up a whole can of worms, but like you said some places produce...

Just to consider the other position, such IMGs (if they have the clinical experience) sound qualified

Curious to see how the FTC Noncompete ban plays into this. I mean, the Supreme Court will kill it, but in the unlikely assumption that it survives, it would protect physicians. Hospitals that claim nonprofit status to avoid the noncompete ban may be subject to having their nonprofit status...

until the very end of my third year of fellowship, I was committed to academic (basic science) BMT Ultimately I did not get funding and received sage advice from a mentor who basically said to do clinical BMT, get paid, and be happy. Working out great!

Agree with all the comments that advise availability to the community I’m three years out from fellowship and now my phone rings with some frequency where I am thinking, “why is this much more experienced oncologist asking me?!” Just saying.

The first year of most (many) IM fellowships is usually worse than intern year, not unique to cardiology. Yes, you will have to start over. Too bad you only have the pretty much the entirety of your residency to do so.

Consider a community position where you will be enrolling lots of trial patients. US Oncology is an example. Agree with the above post but also if you develop a reputation of enrolling lots of good patients for studies, industry will note

Many of the well paying BMT jobs are in groups that really work for it (Northside in Atlanta, Hackensack in NJ, CBCI, etc) and require at least a few years of BMT attending experience. 500-700+ For a new fellowship grad, most available positions will be academic and low paying (unless the...

Fair enough

Only done at few programs which have considerable experience and logistical support and have the right patient population (Hopkins, Vanderbilt, etc) In SCD, donor grafts require marrow, not peripheral blood stem cells, so only places where folks are credentialed to do OR marrow harvests would...

Allo HCT is not what it was in terms of transplant related morbidity and mortality. PTCy, ruxolitinib, ECP, plenty of highly effective GVHD meds. Also, sickle cell does not require any graft versus leukemia effect, so one can crank up the immunosuppression and quash any GVHD without worrying...

Meaning what? Compelling data for haplo in SCD, and it is less costly if less lofty.

Agree with above Also, even if done at select centers, haplo HCT in SCD is curative

You mean, if you have parents/in-laws to take care of the rugrats, you would presumably have more time to focus on your academic work at a highly reputable medical center? Your list makes sense.